Vaginal estrogen for menopause: what it treats, safety and availability

Name: Vaginal estrogen for menopause: what it treats, safety and availability
Creator: MenoWoman

Vaginal estrogen is a low-dose, local treatment for dryness, irritation and painful sex after menopause. It works well, and very little reaches the rest of the body, so it is treated differently from whole-body hormone therapy.

Researched by the MenoWoman team. Edited by Marcela Sat. Updated 7 November 2026. We may earn from links.

Any vaginal bleeding or spotting after menopause needs a doctor's check. Also see a doctor about unusual discharge, pelvic pain, or if you have had breast cancer and are thinking about this treatment.

What it is

Vaginal estrogen puts a small amount of estrogen directly into the vagina. It comes as a cream, a small tablet or insert, or a soft ring that stays in place for weeks.¹⁰

It treats genitourinary syndrome of menopause. This means dryness, burning, irritation, pain during sex and some bladder symptoms caused by low estrogen. The Menopause Society estimates it affects about 27% to 84% of women after menopause.³

Because it is absorbed much less than pills or patches, it is not a treatment for hot flashes.¹⁰

What the research shows

A Cochrane review included 30 trials with 6,235 women. It found low-quality evidence that vaginal estrogen improves symptoms compared with placebo. Creams and rings clearly beat placebo. Results for tablets varied between trials.¹

The same review found creams thickened the womb lining more often than rings. The authors thought this may be because some creams were used at higher doses.¹

The Menopause Society says the different forms work about equally well, so choice can depend on preference.² It recommends prescription options such as vaginal estrogen for moderate to severe symptoms, or when moisturizers and lubricants are not enough.²

NICE in the UK says women can be offered a choice of vaginal estrogen, including those already on systemic HRT. It can continue for as long as needed.⁹

Safety and who should be careful

In 20 trials with 2,983 women followed for up to a year, womb cancer and womb lining overgrowth were rare. Rates were similar to the general population.² The Menopause Society does not advise adding a progestogen for low-risk women on low-dose vaginal estrogen.² Long-term trial data are limited, though observational data are reassuring.² Women at higher risk, such as those with diabetes or obesity, may be offered extra checks.²

Common side effects include breast tenderness, bloating and irritation where it is used. Tell your doctor first if you have had breast, womb or other cancers, blood clots, stroke, heart disease or liver disease.⁷ It should not be used with aromatase inhibitors such as anastrozole or letrozole without specialist advice.^4,7

After breast cancer. ACOG advises trying non-hormonal products first. If they fail, low-dose vaginal estrogen can be considered after weighing risks and benefits. It can be used with tamoxifen. For women on aromatase inhibitors, the decision should be shared with the cancer specialist.⁴

A 2025 meta-analysis of 8 observational studies found vaginal estrogen was not linked to higher breast cancer recurrence or death in survivors. These studies were not randomized, so the results are not conclusive.⁵

How it is available

Vaginal estrogen is usually a prescription medicine. In the UK, the regulator allowed one low-dose estradiol vaginal tablet (Gina 10 microgram) to be sold in pharmacies from September 2022. It is for women aged 50 and over who have had no period for at least a year, after a pharmacist consultation.⁶

In the US, the FDA's 2025-2026 label review included local vaginal products. The Estring vaginal ring was one of the first six products to have its boxed warning removed in February 2026.⁸

Rules differ in other countries. A doctor or pharmacist can explain the options where you live.

What it is used for: evidence rated

Option	Evidence	What the research shows
Vaginal dryness and irritation	Strong evidence	Trials and guidelines support it for vaginal atrophy, though Cochrane rated the evidence quality as low.^1,2
Pain during sex	Strong evidence	Recommended by NICE and The Menopause Society for painful sex caused by menopause.^2,9
Bladder and urinary symptoms	Some evidence	It is commonly used for urinary symptoms linked to menopause, but the trials summarized here focused mainly on vaginal symptoms.^2,10
Hot flashes	Weak evidence	Low-dose vaginal estrogen is mostly absorbed locally and is not used to treat hot flashes.¹⁰

Ratings explained: how we rate. Always talk to a doctor or pharmacist before starting a medicine or supplement.